<DOC>
	<DOCNO>NCT03061799</DOCNO>
	<brief_summary>In woman , age increase , ovarian function lose , result deficiency female hormone , result menopause , menstruation permanently lose . The average age menopause Korean woman 49.7 year old , equivalent 22.3 % total female population . In addition , increase number woman experience early menopause due environmental factor stress result increase number woman enter society also major cause expansion market menopausal woman 's health functional food . Women 's menopausal symptom regard natural process everyone , recent interest health result related study , perception menopausal symptom management necessary spread . In traditional medicine far east asia , danggui ( Angelica gigas Nakai ) , taeunggung ( Cnidium Rhizome ) , broiler ( Cinnamon bark ) commonly use postmenopausal symptom improvement . However , scientific evidence food lack . Therefore , study investigator try examine efficacy safety extract angelica gigas nakai , cnidium rhizome , cinnamon bark postmenopausal symptom . This study design double-blinded placebo control study .</brief_summary>
	<brief_title>Efficacy Safety HPC-03 Postmenopausal Symptom</brief_title>
	<detailed_description>The result preclinical efficacy evaluation HPC-03 ( Angelica gigas Nakai complex extract ) obtain mix material mention showed increase serum estrogen level increase bone mineral density ( BMD ) femur due ALP ( Alkaline phosphatase ) inhibition , bone related index ( BALP , bone-specific alkaline phosphatase ; CTX- 1 , C-terminal telopeptide-1 ; Osteocalcin ) . Therefore , investigator aim confirm safety efficacy HPC-03 ( complex extract Angelica gigas Nakai ) confirm preclinical study , improvement menopausal symptom .</detailed_description>
	<criteria>1 . Women 40 60 year old pass one year since last menstrual period 2 . Women kupperman index score 20 high 3 . Women agree participate trial start clinical trial write informed consent 1 . Women body mass index ( BMI ) great 30 kg / m2 2 . Women use hormone preparation female hormone similar hormone preparation ( plant extract , etc . ) within 3 month 3 . Women history endometrial hyperplasia , uterine cancer , endometrial cancer , breast breast disease , sex hormone relate cancer 4 . A woman history severe migraine within past 1 year , diagnose thromboembolism , cerebrovascular disease , myocardial infarction , unstable angina , coronary angioplasty 5 . Women severe mental illness depression anxiety disorder , currently take psychotropic drug antidepressants 6 . Women irregular uterine bleeding 1 year menopause 7 . Patients uncontrolled hypertension ( 160 / 100mmHg high , 10 minute clinical test subject ) 8 . Patients diabetes whose blood sugar control ( fast glucose 180 mg / dL diabetes mellitus within 3 month ) 9 . Those uncontrolled thyroid disease ( consider able participate trial tester participate ) 10. drug alcohol abuser 11 . If ALT ( Alanine transaminase ) AST ( Aspartate transaminase ) exceed 3 time normal upper limit research institute 12 . If creatinine exceeds twice upper limit normal level research institute 13 . Mammography / PAP smear If clinically significant abnormality ( Breast imagingreporting data system : BIRADS category 0 3 , PAP smear abnormal ASCUS : atypical cell undetermined significance ) confirm ( BIRADS Category 0 , ) 14 . If participate another clinical trial within one month start trial plan participate another clinical trial trial period 15 . If tester judge test inappropriate clinical trial 16 . Women use thyroid hormone preparation , clonidine , anticoagulant antithrombotic agent ( Warfarin , Clopidogrel , etc . ) within 3 month 17 . Women take medicine health functional food related woman 's menopause within month</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>